
Cryomicroneedles for intradermal therapeutic cell delivery
Scientists have developed a new generation of microneedles technology which allows the intradermal delivery of living cells in a minimally invasive manner.
Scientists have developed a new generation of microneedles technology which allows the intradermal delivery of living cells in a minimally invasive manner.
Clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer.
Researchers suggest using microneedles for immunotherapy due to the high abundance of immune cells under the skin. The aim is to vaccinate or treat different diseases with minimal invasiveness.
AI is helping researchers decipher images from a new holographic microscopy technique needed to investigate a key process in cancer immunotherapy “live” as it takes place.
Researchers have successfully designed and tested a system for rapid testing of large numbers of potential immunotherapy drugs.
MIT engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans.
The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo.
Nanoengineers plan to develop an immunotherapy for ovarian cancer using 3D-bioprinted plant virus nanoparticles.
Researchers have developed a new approach to early diagnosis of lung cancer: a urine test that can detect the presence of proteins linked to the disease.
Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.
Using machine learning, researchers have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are likely to benefit from immunotherapy.
Stomach and colorectal cancer: Identifying patients at an early stage who are suitable for artificial intelligence immunotherapy.
Researchers have built a set of magnetic ‘tweezers’ that can position a nano-scale bead inside a human cell in three dimensions with unprecedented precision.
Thanks to developments in 3D bioprinting, the UT researchers could create a miniature brain model representing the delicate tissue around the tumor, including the macrophages.
Several research groups at the Berlin Institute of Health (BIH) are working on digitally combating cancer, comparing experiences with different diagnostic and treatment methods.
In the age of big data, cancer researchers are discovering new ways to monitor the effectiveness of immunotherapy treatments.